Volume Alert - PAH 25.15 Platform Specialty Products Corp.

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2014 at 11:45 AM

Volume Alert - PAH 25.15 Platform Specialty Products Corp. $PAH Hit a high today of 25.42 Closing the day 10:30 at 25.15 +0.14 +0.56% With a day low of 24.70 and a total volume of 2,877,906.

PAH Recent Posts: http://investorshangout.com/Platform-Specialt...PAH-62519/

PAH Platform Specialty Products Corp. Recent Headline News

Platform Specialty Products Corporation Announces Pricing of a $350 Million Public Offering of Common Stock
GlobeNewswire - Wed Nov 12, 7:00AM CST
Platform Specialty Products Corporation (NYSE

AH) ("Platform"

today announced the pricing of an underwritten public offering of 14,300,000 shares of its common stock at a public offering price of $24.50 per share. The gross proceeds to Platform from this offering are expected to be approximately $350 million, before deducting underwriting discounts and commissions and offering expenses payable by Platform. Platform has granted to the underwriters a 30-day option to purchase an additional 2,145,000 shares of its common stock to cover over-allotments, if any. All of the shares of common stock to be sold in the offering are to be sold by Platform. The offering is expected to close on or about November 17, 2014, subject to customary closing conditions.
PAH: 25.10 (+0.09)

Monitoring Avante Logixx Results: Under Promise, Over Deliver
Unconventional Capital Wisdom - at Seeking Alpha - Tue Nov 11, 10:22AM CST

PAH: 25.10 (+0.09)

Platform Specialty Products expects USD350m from planned public offering
M2 - Tue Nov 11, 6:12AM CST
Specialist chemicals company Platform Specialty Products (NYSE

AH) reported on Monday that it intends to start its USD350m public offering of common shares.
PAH: 25.10 (+0.09)

Platform Specialty Products Larger Than S&P 500 Component Allegheny Technologies
TheOnlineInvestor.com - Mon Nov 10, 3:42PM CST
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Platform Specialty Products Corp was identified as having a larger market cap than the smaller end of the S&P 500, for example Allegheny Technologies,...
PAH: 25.10 (+0.09)

Platform Specialty Products Corporation Announces Launch of Public Offering of Common Stock
GlobeNewswire - Mon Nov 10, 6:12AM CST
Platform Specialty Products Corporation (NYSE

AH) ("Platform"

today announced that it has commenced a $350 million underwritten public offering of shares of its common stock. In connection with the offering, Platform intends to grant the underwriters a 30-day option to purchase additional shares of its common stock to cover over-allotments, if any. All of the shares of common stock to be sold in the offering are to be sold by Platform.
PAH: 25.10 (+0.09)

These Six Stocks Are Driving Bill Ackman's Extraordinary 2014 Run
at The Street - Fri Nov 07, 12:01PM CST
It's been a banner year for billionaire hedge fund magnate Bill Ackman -- especially considering just a handful of companies are propelling his big 2014 run.
AGN: 196.88 (+1.54), VRX: 130.49 (+0.46), HHC: 147.10 (+0.07), PAH: 25.10 (+0.09), CP: 209.33 (-0.68), APD: 134.56 (-0.36), BKW: 31.94 (-0.44)

Paul J. Collins Joins Centerview Partners
PR Newswire - Thu Nov 06, 8:00AM CST
Centerview Partners, a leading independent investment banking and advisory firm, announced today that Paul J. Collins has joined the firm as a partner in New York. Mr. Collins brings over 25 years of investment banking experience with deep expertise in chemicals and will enhance Centerview's capabilities in the sector.
BX: 31.89 (+0.27), EMN: 83.45 (-0.88), MRD: 22.94 (-0.75), PAH: 25.10 (+0.09), PPG: 203.48 (-1.78), DOW: 49.99 (+0.47)

Platform Specialty's (PAH) CEO Dan Leever on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 11:42AM CST

PAH: 25.10 (+0.09)

Platform Specialty Products beats by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 7:10AM CST

PAH: 25.10 (+0.09)

Platform Specialty Products Corporation Announces Third Quarter 2014 Financial Results
GlobeNewswire - Wed Nov 05, 7:00AM CST
- Net sales of $197 million, up 4.4% organically
PAH: 25.10 (+0.09)

Chemtura Completes Sale of Its Agrochemicals Business to Platform Specialty Products Corporation
GlobeNewswire - Mon Nov 03, 5:30PM CST
Chemtura Corporation (NYSE:CHMT) (Euronext Paris:CHMT) ("Chemtura"

today announced that it has completed the sale of its agrochemicals business, Chemtura AgroSolutions, to Platform Specialty Products Corporation (NYSE

AH) ("Platform"

, a global specialty chemicals company, for approximately $1 billion, consisting of $950 million in cash and 2 million shares of Platform's common stock. The purchase price is subject to customary post-closing adjustments.
PAH: 25.10 (+0.09), CHMT: 23.51 (+0.03)

Platform Specialty Products Corporation Closes Acquisition of Chemtura AgroSolutions Business and Syndicated $405 Million of Term Loans Facility
GlobeNewswire - Mon Nov 03, 5:27PM CST
- Transaction expected to be immediately accretive to Platform's adjusted earnings, pre-synergies
PAH: 25.10 (+0.09)

Chemtura: A High-Potential Specialty Chemicals Producer
Daniel Lynch - at Seeking Alpha - Fri Oct 24, 3:51PM CDT

ASH: 112.28 (-0.44), GE: 26.43 (+0.05), PAH: 25.10 (+0.09), CHMT: 23.51 (+0.03)

Platform Specialty Products: The Architect And The Builder
Unconventional Capital Wisdom - at Seeking Alpha - Thu Oct 23, 5:15AM CDT

PAH: 25.10 (+0.09)

Why Platform Specialty Products (PAH) Stock Is Gaining Today
at The Street - Mon Oct 20, 2:17PM CDT
Platform Specialty Products (PAH) shares are climbing after the company announced it was purchasing Arysta LifeScience for $3.5 billion.
PAH: 25.10 (+0.09)

Platform Specialty to buy Arysta for $3.51 billion
AP - Mon Oct 20, 9:35AM CDT
NEW YORK (AP) — Platform Specialty Products Corp. said Monday that it will spend about $3.51 billion to buy rival chemical maker Arysta LifeScience Ltd. to diversify its product offerings.
PAH: 25.10 (+0.09)

Permira Books $3.5 Billion Exit From Ireland-based Arysta LifeScience
at The Street - Mon Oct 20, 9:06AM CDT
Sale to Martin Franklin's chemicals rollup Platform Specialty Products provides the London firm with a 1.7 times return on investment.
PAH: 25.10 (+0.09), CHMT: 23.51 (+0.03)

Platform to buy chemicals maker Arysta for $3.51B
Seeking Alpha - at Seeking Alpha - Mon Oct 20, 7:06AM CDT

PAH: 25.10 (+0.09)

Platform Specialty Products Corporation Announces Preliminary Third Quarter Financial Results Record Q3 Adjusted EBITDA
GlobeNewswire - Mon Oct 20, 6:15AM CDT
- Net sales expected to be approximately $195 million to $197 million
PAH: 25.10 (+0.09)

Platform Specialty Products Corporation Signs Definitive Agreement to Acquire Arysta LifeScience Limited for Approximately $3.51 Billion
GlobeNewswire - Mon Oct 20, 6:14AM CDT
- Acquisition expected to be immediately accretive to Platform's adjusted earnings per share, pre-synergies
PAH: 25.10 (+0.09)

Element Solutions Inc. (ESI) Stock Research Links

ESI Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Ping An's Bold Green Moves Ahead of APEC 2026

By Owen Jenkins Updated Oct 25, 2026 Category News Views 163

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

RYBREVANT's Promising Results in HNSCC Treatment

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...